HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Regression of Marginal Zone Lymphoma After Praziquantel Therapy in a Patient With Remote Schistosoma haematobium Infection.

AuthorsMyint B Thu, Nyein N Htun, Khin H H Soe, Amir Steinberg, George McKinley, Mala Varma, Joseph Yoe
JournalClinical lymphoma, myeloma & leukemia (Clin Lymphoma Myeloma Leuk) Vol. 21 Issue 4 Pg. e353-e355 (04 2021) ISSN: 2152-2669 [Electronic] United States
PMID33509726 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Anthelmintics
  • Praziquantel
Topics
  • Adult
  • Animals
  • Anthelmintics (therapeutic use)
  • Female
  • Humans
  • Lymphoma, B-Cell, Marginal Zone (complications, diagnosis, drug therapy)
  • Praziquantel (therapeutic use)
  • Schistosoma haematobium (isolation & purification)
  • Schistosomiasis haematobia (complications, diagnosis, drug therapy, parasitology)
  • Treatment Outcome

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: